The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021 when £4.5bn was raised. The UK biotech ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

An upstart biopharma firm founded by two former executives at CinCor Pharma – which celebrated a $1.8B exit to AstraZeneca in ...

Medical research cuts are shaping up as an election issue as the Coalition accuses Labor of undermining efforts to ...

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

BMO Capital analyst Kostas Biliouris has maintained their bullish stance on LEGN stock, giving a Buy rating yesterday.Invest with Confidence: ...

Genmab (NASDAQ:GMAB), a biotechnology company with a market capitalization of $16.91 billion specializing in cancer ...

BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Life Biosciences ("Life Bio”), a biotechnology company pioneering cellular ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

The Trump administration has pressed the pause button on the US’ vital biomedical research engine, the National Institutes ...

In this conversation, the Business Journal invites Cadrenal Founder & CEO Quang Pham to talk about the biopharmaceutical ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.